Vanguard Group Inc Anixa Biosciences Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,392,906 shares of ANIX stock, worth $5.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,392,906
Previous 1,392,906
-0.0%
Holding current value
$5.82 Million
Previous $3.98 Million
15.39%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.33MCall Options Held
14.1KPut Options Held
12.1K-
Laird Norton Trust Company, LLC617KShares$2.58 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2.57 Million0.01% of portfolio
-
Ubs Group Ag505KShares$2.11 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.54 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA343KShares$1.43 Million0.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $128M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...